IL9 and B-cell chronic lymphocytic leukemia: Moreover, IL-9 blockade in the CLL mouse model Eμ-TCL1 decreases leukemic cell invasiveness and disease burden [15, 17], suggesting a role for IL-9 in CLL pathogenesis.